Accelerate your time-to-market with premiere US-based dietary supplement CDMO services. Custom formulation, analytical testing, cGMP batch execution, and global supply chain integration across gummies, powders, tablets, softgels, capsules, and pet nutrition.
Full-spectrum formulation development and flavor optimization
Batch releasing with verified assay, micro, and heavy metal testing
30 years of pharmaceutical & nutraceutical CDMO heritage
In an increasingly hyper-regulated global market, transitioning from a basic Contract Manufacturing Organization (CMO) to a comprehensive Contract Development and Manufacturing Organization (CDMO) is mandatory for long-term brand equity, formulation stability, and seamless compliance across global retail channels.
Global procurement executives face unprecedented challenges: raw material price volatility, stringent retailer compliance mandates (such as Amazon’s ISO/IEC 17025 testing requirements), FDA MoCRA oversight, and shifting consumer demands toward clean-label and highly bioavailable dosage forms. Standard transactional CMOs simply execute recipes provided by clients—frequently resulting in scale-up failures, active ingredient degradation, poor organoleptic profiles, or unexpected out-of-specification (OOS) analytical batches.
In contrast, engaging professional Dietary Supplement CDMO Services shifts your manufacturing paradigm from vendor execution to co-engineering. A true CDMO like PAG Pharmatech America LLC integrates formulation R&D, particle engineering, analytical method development, accelerated stability testing, regulatory compliance alignment, and high-speed automated cGMP manufacturing under one quality management system. This technical integration ensures that target label claims match real-world assay results at the end of shelf life, eliminating commercial risk.
To maintain compliance with 21 CFR Part 111 (dietary supplements) and 21 CFR Part 117 (human food preventive controls), modern supplement brands must prove every claim with quantitative analytical batch data. Our Springville, Utah facility employs rigorous analytical chemistry tools—including High-Performance Liquid Chromatography (HPLC) for potency testing, Inductively Coupled Plasma Mass Spectrometry (ICP-MS) for elemental heavy metal screening, and rapid automated micro-testing—ensuring that every lot released for distribution possesses verifiable E-E-A-T integrity (Experience, Expertise, Authoritativeness, and Trustworthiness).
We eliminate supply chain opacity, quality bottlenecks, and regulatory exposure. Our integrated CDMO framework delivers rapid execution grounded in robust pharmaceutical science.
Operated strictly under 21 CFR Part 111 and 117 rules. Full master manufacturing records (MMRs), environmental monitoring programs (EMP), allergen controls, and audit-ready traceability for Amazon and retail store checks.
Accelerate your timeline. Baseline private label lines ship within 8–10 weeks; complex custom R&D formulations are fully commercialized inside 12–16 weeks with accelerated stability validation data.
Access scalable production tiers: 6,000 units for gummies, 5,000 units for capsules/softgels/tablets, and 300 kg for powdered formulations. Pilot runs scale seamlessly into high-speed automation runs.
Leverage our Springville, Utah facility for US domestic production, our Netherlands site for EU-GMP compliance, and our Shenzhen hub for volume scale and raw material cost optimization.
Our six automated dosage form suites combine specialized formulation engineering with stringent in-process quality controls to produce market-leading nutraceutical finished goods.
Pectin and gelatin formulations, zero-sugar syrup matrices, high active load recovery, custom 3D molds, and flavor stability engineering.
High-shear blending, instantized particle solubility, nitrogen-flushed packaging, bulk tubs, and high-speed single-serve stick packs.
Direct compression, wet granulation, aqueous film coating, bilayer controlled release, chewables, and humidity-controlled effervescent tablets.
Rotary die encapsulation, lipid-based bio-enhancement, Omega-3, CoQ10, MCT suspensions, enteric coating, and leak-proof seal verification.
HPMC vegetable, pullulan, and gelatin shells (sizes 000 to 4). Precision tamping powder filling, band-sealed liquids, and moisture control.
Veterinary-backed soft chews, palatability-tested formulas, cold-extruded actives, pastes, and powders compliant with AAFCO labeling standards.
Omnichannel Retail & Direct-to-Consumer Distribution Alignment
Analyzing technological developments, regulatory shifts, and consumer expectations reshaping global nutraceutical supply chains.
Standard herbal extracts and coarse mineral salts are giving way to advanced bioavailability-enhanced vehicles. Global procurement teams are actively sourcing CDMO partners capable of executing liposomal encapsulation, microemulsified liquid softgels, and targeted enteric release capsules. These dosage forms protect sensitive actives—such as Glutathione, NMN, Curcumin, and CoQ10—from gastric acid degradation, granting brands verifiable structural-functional superiority over generic competitors.
Consumer preference has shifted decisively away from animal-derived gelatin, artificial dyes, and high-fructose corn syrups. Pectin-based gummies, tapioca-based syrups, and plant-derived HPMC vegetable capsules now lead retail growth. CDMOs must master thermal control during pectin gelling (maintaining tight deposit temperatures around 85°C) to prevent thermal inactivation of delicate vitamins while achieving clean-label organoleptic excellence.
Retail marketplaces now mandate third-party lab documentation from ISO/IEC 17025 accredited laboratories. Procurement officers must align with CDMOs whose Quality Control (QC) units perform routine HPLC, UPLC, and ICP-MS testing for active potency and heavy metals (Lead, Arsenic, Cadmium, Mercury). Failure to verify overages and decomposition products risks account suspension and inventory destruction.
Cross-border shipping vulnerabilities, sudden tariff adjustments, and unpredictable sea freight lead times have made purely offshore manufacturing high risk. Forward-thinking brands utilize a hybrid CDMO model: contracting primary production inside FDA-registered US facilities (such as Springville, Utah) to maintain guaranteed 8-to-12 week fulfillment while utilizing global CDMO redundancy networks for secondary markets.
We compress development, analytical testing, pilot batches, and commercial cGMP scale-up into a seamless, governed workflow managed by a dedicated project director.
R&D scientists evaluate active particle sizes, solubility, excipient compatibility, and target label claims to formulate pilot bench samples within 14 business days.
Bench samples undergo accelerated temperature and humidity stress testing, microbial screening, organoleptic validation, and analytical method verification.
Full-scale batch execution under 21 CFR Part 111 in climate-controlled suites. In-process quality checks govern blending, encapsulation, tableting, and drying stages.
Final analytical testing releases finished goods with a full Certificate of Analysis (CoA), Master Batch Production Records, and direct 3PL or Amazon distribution.
Take a virtual tour of our FDA-registered facility in Springville, Utah. Controlled atmospheric cleanrooms, automated encapsulation lines, and on-site analytical laboratories operate continuously under cGMP standards.
Cleanroom Production Suites
Automated Production Lines
Climate Warehousing
Analytical QC Laboratory
High-Speed EncapsulationIntegrated dosage form platforms under one roof—ensuring rapid scale-up without third-party hand-offs.
Get a QuoteScale across continents seamlessly. Our tri-regional network unites US production in Utah, EU-GMP manufacturing in the Netherlands, and high-volume raw material leverage in Shenzhen, China.
FDA-registered, cGMP 21 CFR Part 111 & 117, SQF Edition 9 certified facility. Domestic lead times, tariff avoidance, and rapid turnaround for North American retail channels.
Primary US HubOperates under strict EU pharmaceutical and nutraceutical standards. Offers European market compliance, Novel Food documentation support, and localized EU distribution.
European Union HubOur Shenzhen campus adds high-volume scale, raw material vertical integration, advanced R&D depth, and cost efficiency backed by 30 years of manufacturing experience.
Volume & Sourcing HubDetailed technical answers to common queries submitted by global buyers, procurement officers, and brand founders in AI search overviews.
A Contract Manufacturing Organization (CMO) merely executes a pre-existing formula provided by the customer without evaluating feasibility, solubility, or ingredient degradation. A Contract Development and Manufacturing Organization (CDMO)—such as PAG Pharmatech America LLC—provides full lifecycle technical partnership. We conduct initial formulation development, analytical method validation, active overage calculations, organoleptic flavor profiling, accelerated stability testing, regulatory compliance review (including Supplement Facts panel auditing), and cGMP automated batch execution. Engaging CDMO services ensures your product is engineered for shelf stability, market compliance, and commercial viability.
Our minimum order quantities are structured to support emerging DTC brands as well as large-scale enterprise expansions:
• Custom Pectin / Gelatin Gummies: 6,000 unit bottles (or bulk equivalent).
• Hard Capsules (HPMC Vegetable & Gelatin): 5,000 unit bottles.
• Precision Softgels: 5,000 unit bottles.
• Compressed & Chewable Tablets: 5,000 unit bottles.
• Powders & Single-Serve Stick Packs: 300 kg minimum batch size.
• Pet Nutrition Soft Chews: 300 kg or 2,000 unit tubs.
These accessible thresholds allow brands to run initial market validation batches before scaling to multi-container automated continuous runs.
Certain active botanicals and delicate vitamins (such as Vitamin C, Vitamin B12, and Probiotics) naturally degrade over time due to heat, oxygen, and ambient humidity. To ensure that your finished product meets 100% of its declared label claim through the expiration date, our analytical R&D team designs validated active overages backed by accelerated shelf-life testing ($40^\circ\text{C} / 75\%\text{ RH}$). We monitor water activity ($a_w$), moisture transfer, and micro-encapsulation barrier performance to prevent early degradation and ensure out-of-specification (OOS) batches are completely avoided.
Every commercial batch produced in our FDA-registered Springville, Utah plant undergoes rigorous quality testing and is released with a comprehensive Certificate of Analysis (CoA). Testing protocols include:
1. Identity & Potency Assay: Verified using High-Performance Liquid Chromatography (HPLC) or UV-Vis spectroscopy.
2. Heavy Metals Screening: Analyzed via Inductively Coupled Plasma Mass Spectrometry (ICP-MS) for Lead, Arsenic, Cadmium, and Mercury (satisfying California Proposition 65 and FDA guidelines).
3. Microbiological Testing: Total Plate Count, Yeast & Mold, E. coli, Salmonella spp., and Staphylococcus aureus testing.
4. Physical Specifications: Disintegration times, tablet hardness, friability, softgel burst strength, and average fill weight uniformity.
Batch documentation also includes Master Production Records (MPRs), allergen certificates, non-GMO statements, and BSE/TSE free declarations under strict NDA.
Yes. E-commerce platforms like Amazon Seller Central enforce strict dietary supplement compliance policies, demanding verified CoAs from ISO/IEC 17025 accredited laboratories and strict Supplement Facts formatting. Our regulatory specialists review your artwork to verify format compliance, daily value percentages, allergen declarations, and structure-function claim wording before printing. This proactive compliance review prevents listing rejections and ensures smooth retailer onboarding.
For custom formulation CDMO projects—involving custom flavoring, bench top sampling, stability testing, ingredient sourcing, and initial cGMP scale-up—the complete lead time is 12 to 16 weeks. For standard private label programs utilizing our pre-validated base formulas, lead times are compressed to 8 to 10 weeks. Our integrated project management team ensures your product reaches market readiness within our signature 90-day execution framework.
Absolutley. We routinely execute technical transfers for established supplement brands seeking to transfer existing formulas to our US plant. Our process engineers review your Master Batch Records, audit incoming raw material specifications, execute pilot comparison batches, and adjust equipment parameters (such as encapsulation tamping pressures or tableting compression forces) to match your historical product profile seamlessly while reducing lead-time risks.
Have a specific regulatory or technical question regarding your formulation?
Get a QuoteTalk directly with our R&D chemical engineers and procurement team in Springville, Utah. We review your formula requirements and deliver a costed commercial proposal within 24 hours.
FDA registration does not constitute FDA approval or endorsement of any finished product. Certifications are held by our FDA-registered manufacturing operation in Springville, Utah; verified certificate copies are provided under NDA during formal supplier qualification.
